The Newsroom

Investigations  /  03.08.2019

Shareholder Investigation of Syneos Health

Syneos Health, Inc. (SYNH) Accused of Improper Accounting Practices

According to the complaint against the company’s officers and directors for alleged violations of the Securities Exchange Act of 1934 between May 10, 2017 and February 27, 2019, on various quarterly and annual reports since 2017, Syneos Health, Inc. (SYNH) stated that its internal control over financial reporting was effective. However, on February 27, 2019, after market hours, Syneos announced it was delaying the release of its Form 10-K after the U.S. Securities and Exchange Commission started an investigation into Syenos’ revenue accounting policies and internal controls. On this news, shares of Syneos fell $10.24 per share or almost 20% to close at $41.77 per share on February 28, 2019.

Syneos Health, Inc. (SYNH) Shareholders Have Legal Options

Concerned shareholders who would like more information about their rights and potential remedies can please send us a message via the Shareholder Information form below.

Shareholder Information

  • Please Note: Neither the submission to nor the receipt of information by Robbins Arroyo LLP or one of its attorneys through this website constitutes an agreement by our firm to represent the individual and does not create an attorney-client relationship. Please do not send confidential or sensitive information through this website. This information should be communicated through a direct contact with an individual at the firm.

Please Note: Neither the submission to nor the receipt of information by Robbins Arroyo LLP or one of its attorneys through this website constitutes an agreement by our firm to represent the individual and does not create an attorney-client relationship. Please do not send confidential or sensitive information through this website. This information should be communicated through a direct contact with an individual at the firm.

How can we help you?

CONTACT US TODAY | 1-800-350-6003 or info@robbinsarroyo.com

Tell us your concerns